You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
Researchers have identified immune cell gene expression signatures that could one day be developed into tests to predict response to treatment.
Using a mouse model of immunotherapy resistant disease, the researchers found that this program could be targeted by an inhibitor to improve response.
Two new studies have uncovered expression-defined T cell subsets that seem to coincide with better or worse outcomes in breast cancer or non-small cell lung cancer.
